Acebutolol hydrochloride and Oesophageal carcinoma - a phase IV clinical study of FDA data

Summary:

Oesophageal carcinoma is reported only by a few people who take Acebutolol Hydrochloride.

The phase IV clinical study analyzes which people take Acebutolol hydrochloride and have Oesophageal carcinoma. It is created by eHealthMe based on reports of 1,195 people who have side effects while taking Acebutolol hydrochloride from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

1,195 people reported to have side effects when taking Acebutolol hydrochloride.
Among them, 1 person (0.08%) has Oesophageal carcinoma.

What is Acebutolol hydrochloride?

Acebutolol hydrochloride has active ingredients of acebutolol hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 1,260 Acebutolol hydrochloride users for its effectiveness, alternative drugs and more.

What is Oesophageal carcinoma?

Oesophageal carcinoma (cancer tumour of oesophagus) is found to be associated with 759 drugs and 388 conditions by eHealthMe.

Number of Acebutolol hydrochloride and Oesophageal carcinoma reports submitted per year:

Could Acebutolol hydrochloride cause Oesophageal carcinoma?

Gender of people who have Oesophageal carcinoma when taking Acebutolol hydrochloride *:

female: 0.0 %
male: 100 %

Age of people who have Oesophageal carcinoma when taking Acebutolol hydrochloride *:

Common drugs people take besides Acebutolol hydrochloride *:

Perindopril Erbumine: 1 person, 100.00%
Atorvastatin Calcium: 1 person, 100.00%

Common side effects people have besides Oesophageal carcinoma *:

Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 1 person, 100.00%
Mouth Ulcers: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Acebutolol hydrochloride and have Oesophageal carcinoma?

Check whether Oesophageal carcinoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Browse all side effects of Acebutolol hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Oesophageal carcinoma treatments and more:

Oesophageal carcinoma (33,075 reports)

COVID vaccines that are related to Oesophageal carcinoma:

Common drugs associated with Oesophageal carcinoma:

All the drugs that are associated with Oesophageal carcinoma:

Oesophageal carcinoma (759 drugs)

Common conditions associated with Oesophageal carcinoma:

All the conditions that are associated with Oesophageal carcinoma:

Oesophageal carcinoma (388 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acebutolol hydrochloride (the active ingredients of Acebutolol hydrochloride) and Acebutolol hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.